Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 7
2004 7
2005 9
2006 3
2007 8
2008 7
2009 5
2010 8
2011 8
2012 9
2013 15
2014 15
2015 13
2016 20
2017 23
2018 9
2019 22
2020 27
2021 32
2022 34
2023 28
2024 12
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Results by year

Filters applied: . Clear all
Page 1
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Davis ID, et al. N Engl J Med. 2019 Jul 11;381(2):121-131. doi: 10.1056/NEJMoa1903835. Epub 2019 Jun 2. N Engl J Med. 2019. PMID: 31157964 Clinical Trial.
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Sweeney CJ, Martin AJ, Stockler MR, Begbie S, Cheung L, Chi KN, Chowdhury S, Frydenberg M, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Vera-Badillo F, Williams SG, Winter D, Yip S, Zhang AY, Zielinski RR, Davis ID; ENZAMET trial investigators and Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Sweeney CJ, et al. Lancet Oncol. 2023 Apr;24(4):323-334. doi: 10.1016/S1470-2045(23)00063-3. Lancet Oncol. 2023. PMID: 36990608 Clinical Trial.
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical Trial.
Alexander M, Harris S, Underhill C, Torres J, Sharma S, Lee N, Wong H, Eek R, Michael M, Tie J, Rogers J, Heriot AG, Ball D, MacManus M, Wolfe R, Solomon BJ, Burbury K. Alexander M, et al. Among authors: torres j. JAMA Oncol. 2023 Nov 1;9(11):1536-1545. doi: 10.1001/jamaoncol.2023.3634. JAMA Oncol. 2023. PMID: 37733336 Free PMC article.
Microbiome-MX 2018: microbiota and microbiome opportunities in Mexico, a megadiverse country.
Cornejo-Granados F, Calderón de la Barca AM, Torres N, Martínez-Romero E, Torres J, López-Vidal Y, Soberón X, Partida-Martínez LP, Pinto-Cardoso S, Alcaraz LD, Pardo-López L, Canizales-Quinteros S, Puente JL, Ochoa-Leyva A. Cornejo-Granados F, et al. Among authors: torres j. Res Microbiol. 2019 Jun-Aug;170(4-5):235-241. doi: 10.1016/j.resmic.2019.03.001. Epub 2019 Mar 25. Res Microbiol. 2019. PMID: 30922683 Free article.
Response to: Lyme Neuroborreliosis in Mexico.
Gordillo-Pérez G, Solórzano-Santos F, Torres J. Gordillo-Pérez G, et al. Among authors: torres j. Arch Med Res. 2019 Jan;50(1):1. doi: 10.1016/j.arcmed.2019.03.006. Epub 2019 Apr 4. Arch Med Res. 2019. PMID: 31101235 No abstract available.
Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy.
Anguita-Gámez M, Vivas D, Ferrandis R, González-Manzanares R, Anguita M, Esteve-Pastor MA, Echeverri M, Igualada J, Egocheaga I, Nozal-Mateo B, Abad-Motos A, Figuero E, Bouzó-Molina N, Lozano T, Álvarez-Ortega C, Torres J, Descalzo MJ, Catalá JC, Martín-Rioboo E, Molines A, Rodríguez-Contreras R, Carnero-Alcázar M, Marín F; REQXAA Investigators. Anguita-Gámez M, et al. Among authors: torres j. Med Clin (Barc). 2024 Oct 18;163(7):336-343. doi: 10.1016/j.medcli.2024.04.020. Epub 2024 Jul 2. Med Clin (Barc). 2024. PMID: 38955604 English, Spanish.
297 results